Weiguang Bio (002880.SZ) released its semi-annual performance, with a net profit attributable to shareholders of 108 million yuan, a decrease of 2.02%

Zhixin Finance APP News, Weiguang Biological (002880.SZ) released its interim report for the first half of 2025. The company's operating income was 518 million yuan, a decrease of 0.92% year-on-year. Net profit attributable to the company's shareholders was 108 million yuan, a decrease of 2.02% year-on-year. Net profit attributable to the company's shareholders after deducting non-recurring gains and losses was 106 million yuan, a decrease of 1.36% year-on-year. Basic earnings per share was 0.4746 yuan.